Iradimed Co (IRMD)

Currency in USD
57.80
+0.69(+1.21%)
Closed·
After Hours
57.800.00(0.00%)
·
IRMD Scorecard
Full Analysis
Trading at a high earnings multiple
IRMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
57.5358.51
52 wk Range
42.3463.29
Key Statistics
Prev. Close
57.11
Open
57.72
Day's Range
57.53-58.51
52 wk Range
42.34-63.29
Volume
29.58K
Average Volume (3m)
47.27K
1-Year Change
20.21%
Book Value / Share
7.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IRMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
71.00
Upside
+22.84%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Iradimed Co News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Iradimed Co Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Iradimed Co Earnings Call Summary for Q1/2025

  • Q1 2025 revenue up 11% YoY to $19.5M; EPS of $0.42 beats $0.41 forecast; domestic sales surge 19%, making up 82% of total revenue
  • Gross margin steady at 76.1%; company maintains 'GREAT' financial health score of 3.54/5; stock rises 0.77% in pre-market trading
  • Q2 2025 revenue guidance: $19.7M-$19.9M; Full-year 2025 forecast: $78M-$82M revenue, $1.55-$1.65 GAAP EPS
  • CEO confident in operational plans; new facility occupancy expected July; potential risks include FDA clearance delays and international sales decline
Last Updated: 05/05/2025, 14:40
Read Full Transcript

Compare IRMD to Peers and Sector

Metrics to compare
IRMD
Peers
Sector
Relationship
P/E Ratio
37.1x−8.1x−0.5x
PEG Ratio
3.46−0.290.00
Price/Book
8.2x5.9x2.6x
Price / LTM Sales
9.8x3.4x3.2x
Upside (Analyst Target)
22.8%66.1%41.2%
Fair Value Upside
Unlock5.2%6.2%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 71.00
(+22.84% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.56%
Dividend Yield
1.18%
Industry Median 1.34%
Annualised payout
0.68
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 05, 2025
EPS / Forecast
0.42 / 0.41
Revenue / Forecast
19.50M / 19.13M
EPS Revisions
Last 90 days

IRMD Income Statement

People Also Watch

233.32
POWL
-3.75%
152.08
KRYS
-0.54%
91.91
BRO
-10.40%
160.63
HWKN
-0.14%
82.44
LMAT
-0.04%

FAQ

What Stock Exchange Does Iradimed Co Trade On?

Iradimed Co is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Iradimed Co?

The stock symbol for Iradimed Co is "IRMD."

What Is the Iradimed Co Market Cap?

As of today, Iradimed Co market cap is 734.55M.

What Is Iradimed Co's Earnings Per Share (TTM)?

The Iradimed Co EPS (TTM) is 1.56.

When Is the Next Iradimed Co Earnings Date?

Iradimed Co will release its next earnings report on 31 Jul 2025.

From a Technical Analysis Perspective, Is IRMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Iradimed Co Stock Split?

Iradimed Co has split 0 times.

How Many Employees Does Iradimed Co Have?

Iradimed Co has 160 employees.

What is the current trading status of Iradimed Co (IRMD)?

As of 30 Jul 2025, Iradimed Co (IRMD) is trading at a price of 57.80, with a previous close of 57.11. The stock has fluctuated within a day range of 57.53 to 58.51, while its 52-week range spans from 42.34 to 63.29.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.